Immuno-Oncology: The Third Paradigm in Early Drug Development Juan Martin-LiberalCinta HierroJordi Rodon Leading Article 20 December 2016 Pages: 125 - 138
The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities Nicole J. FlynnRajasekharan SomasundaramJennifer Sims-Mourtada Review Article 09 March 2017 Pages: 139 - 152
Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Salvatore CoralloEttore D’ArgentoCarlo M. Barone Review Article 10 February 2017 Pages: 153 - 161
Exploiting microRNAs As Cancer Therapeutics Tamsin RobbGlen ReidCherie Blenkiron Review Article 30 January 2017 Pages: 163 - 178
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives Mateusz FlorczukAdam SzpechcinskiJoanna Chorostowska-Wynimko Review Article Open access 27 February 2017 Pages: 179 - 200
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance) Joleen M. HubbardMichelle R. MahoneySteven R. Alberts Original Research Article 09 December 2016 Pages: 201 - 209
Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy Yu Jin LimJaemoon KohYung-Jue Bang Original Research Article 13 January 2017 Pages: 211 - 218
Risk of Second Primary Malignancies in Lung Cancer Survivors – The Influence of Different Treatments Vincent Yi-Fong SuChia-Jen LiuYu-Wen Hu Original Research Article 20 October 2016 Pages: 219 - 227
Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer Michael KosminAndreas MakrisAnwar R. Padhani Short Communication 21 January 2017 Pages: 229 - 234
Anti-PD-L1 atezolizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Literature Laura HickmottHugo De La PeñaAvinash Gupta Therapy in Practice 02 March 2017 Pages: 235 - 241
Sorafenib: A Review in Hepatocellular Carcinoma Gillian M. Keating Adis Drug Evaluation 15 March 2017 Pages: 243 - 253
Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma Sohita Dhillon Adis Drug Evaluation 21 March 2017 Pages: 255 - 262
Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines Yi ShiLin SunWanguo Wei Erratum 24 January 2017 Pages: 263 - 263
